Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells

  • Ellen Weisberg ,

    Contributed equally to this work with: Ellen Weisberg, Arghya Ray

    ellen_weisberg@dfci.harvard.edu

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Arghya Ray ,

    Contributed equally to this work with: Ellen Weisberg, Arghya Ray

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Erik Nelson,

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Sophia Adamia,

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Rosemary Barrett,

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Martin Sattler,

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Chengsheng Zhang,

    Affiliation Cytogenetic Core Facility, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • John F. Daley,

    Affiliation Hematologic Neoplasia Flow Cytometry Facility, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • David Frank,

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • Edward Fox,

    Affiliation Molecular Diagnostics Laboratory, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  • James D. Griffin

    Affiliation Department of Medical Oncology/Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.